BIOGEN INC (IDP.DE) Stock Fundamental Analysis
FRA:IDP - Deutsche Boerse Ag - US09062X1037 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to IDP. IDP was compared to 71 industry peers in the Biotechnology industry. IDP has an excellent profitability rating, but there are some minor concerns on its financial health. IDP is valued quite cheap, but it does not seem to be growing. This makes IDP very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year IDP was profitable.
In the past year IDP had a positive cash flow from operations.
In the past 5 years IDP has always been profitable.
IDP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IDP's Return On Assets of 5.82% is amongst the best of the industry. IDP outperforms 85.92% of its industry peers.
IDP has a Return On Equity of 9.76%. This is amongst the best in the industry. IDP outperforms 83.10% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.92%, IDP belongs to the top of the industry, outperforming 87.32% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IDP is below the industry average of 13.79%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.82% | ||
| ROE | 9.76% | ||
| ROIC | 9.92% |
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
1.3 Margins
IDP's Profit Margin of 16.87% is amongst the best of the industry. IDP outperforms 88.73% of its industry peers.
IDP's Profit Margin has declined in the last couple of years.
The Operating Margin of IDP (26.35%) is better than 88.73% of its industry peers.
IDP's Operating Margin has declined in the last couple of years.
The Gross Margin of IDP (76.12%) is better than 77.46% of its industry peers.
IDP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.35% | ||
| PM (TTM) | 16.87% | ||
| GM | 76.12% |
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IDP is still creating some value.
The number of shares outstanding for IDP has been increased compared to 1 year ago.
Compared to 5 years ago, IDP has less shares outstanding
IDP has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.62 indicates that IDP is not a great score, but indicates only limited risk for bankruptcy at the moment.
IDP's Altman-Z score of 2.62 is fine compared to the rest of the industry. IDP outperforms 76.06% of its industry peers.
The Debt to FCF ratio of IDP is 2.50, which is a good value as it means it would take IDP, 2.50 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IDP (2.50) is better than 95.77% of its industry peers.
IDP has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.27, IDP is doing good in the industry, outperforming 61.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 2.5 | ||
| Altman-Z | 2.62 |
ROIC/WACC1.02
WACC9.71%
2.3 Liquidity
A Current Ratio of 1.35 indicates that IDP should not have too much problems paying its short term obligations.
IDP has a worse Current ratio (1.35) than 66.20% of its industry peers.
IDP has a Quick Ratio of 1.35. This is a bad value and indicates that IDP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of IDP (0.90) is worse than 64.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.9 |
3. Growth
3.1 Past
IDP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.22%, which is quite good.
IDP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.31% yearly.
Looking at the last year, IDP shows a decrease in Revenue. The Revenue has decreased by -1.62% in the last year.
Measured over the past years, IDP shows a decrease in Revenue. The Revenue has been decreasing by -7.62% on average per year.
EPS 1Y (TTM)9.22%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%4.24%
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%2.87%
3.2 Future
Based on estimates for the next years, IDP will show a small growth in Earnings Per Share. The EPS will grow by 1.94% on average per year.
The Revenue is expected to decrease by -0.29% on average over the next years.
EPS Next Y-2.34%
EPS Next 2Y-0.8%
EPS Next 3Y1.99%
EPS Next 5Y1.94%
Revenue Next Year-4.32%
Revenue Next 2Y-2.38%
Revenue Next 3Y-0.89%
Revenue Next 5Y-0.29%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.17, the valuation of IDP can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of IDP indicates a rather cheap valuation: IDP is cheaper than 95.77% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of IDP to the average of the S&P500 Index (28.79), we can say IDP is valued rather cheaply.
IDP is valuated cheaply with a Price/Forward Earnings ratio of 7.35.
Based on the Price/Forward Earnings ratio, IDP is valued cheaper than 97.18% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.38. IDP is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.17 | ||
| Fwd PE | 7.35 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IDP is valued cheaper than 88.73% of the companies in the same industry.
IDP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IDP is cheaper than 97.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.87 | ||
| EV/EBITDA | 6.67 |
4.3 Compensation for Growth
IDP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.8%
EPS Next 3Y1.99%
5. Dividend
5.1 Amount
No dividends for IDP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:IDP (4/25/2025, 7:00:00 PM)
103.85
-1.65 (-1.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners94.24%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap15.20B
Analysts74.42
Price Target168.1 (61.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.08%
Min EPS beat(2)0.67%
Max EPS beat(2)5.5%
EPS beat(4)4
Avg EPS beat(4)9.77%
Min EPS beat(4)0.67%
Max EPS beat(4)28.61%
EPS beat(8)8
Avg EPS beat(8)6.83%
EPS beat(12)11
Avg EPS beat(12)8.87%
EPS beat(16)14
Avg EPS beat(16)9.1%
Revenue beat(2)1
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-0.68%
Max Revenue beat(2)0.11%
Revenue beat(4)2
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-2.86%
Max Revenue beat(4)1.48%
Revenue beat(8)5
Avg Revenue beat(8)0.17%
Revenue beat(12)7
Avg Revenue beat(12)0.42%
Revenue beat(16)10
Avg Revenue beat(16)0.84%
PT rev (1m)-2.96%
PT rev (3m)-20.72%
EPS NQ rev (1m)-3.76%
EPS NQ rev (3m)-11.84%
EPS NY rev (1m)-0.51%
EPS NY rev (3m)-5.71%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-3.66%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)-3.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.17 | ||
| Fwd PE | 7.35 | ||
| P/S | 1.79 | ||
| P/FCF | 6.87 | ||
| P/OCF | 6.01 | ||
| P/B | 1.03 | ||
| P/tB | 31.68 | ||
| EV/EBITDA | 6.67 |
EPS(TTM)14.48
EY13.94%
EPS(NY)14.14
Fwd EY13.61%
FCF(TTM)15.11
FCFY14.55%
OCF(TTM)17.27
OCFY16.63%
SpS58.11
BVpS100.39
TBVpS3.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.82% | ||
| ROE | 9.76% | ||
| ROCE | 11.32% | ||
| ROIC | 9.92% | ||
| ROICexc | 11.09% | ||
| ROICexgc | 56.18% | ||
| OM | 26.35% | ||
| PM (TTM) | 16.87% | ||
| GM | 76.12% | ||
| FCFM | 26% |
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
ROICexc(3y)12.43%
ROICexc(5y)16.11%
ROICexgc(3y)38.35%
ROICexgc(5y)40.12%
ROCE(3y)12.07%
ROCE(5y)15.58%
ROICexcg growth 3Y14.15%
ROICexcg growth 5Y-5.35%
ROICexc growth 3Y-15.93%
ROICexc growth 5Y-20.8%
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
F-Score6
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 2.5 | ||
| Debt/EBITDA | 1.41 | ||
| Cap/Depr | 53.45% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 10.39 | ||
| Cash Conversion | 89.23% | ||
| Profit Quality | 154.13% | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | 2.62 |
F-Score6
WACC9.71%
ROIC/WACC1.02
Cap/Depr(3y)54.43%
Cap/Depr(5y)68.89%
Cap/Sales(3y)3.09%
Cap/Sales(5y)3.21%
Profit Quality(3y)99.34%
Profit Quality(5y)120.98%
High Growth Momentum
Growth
EPS 1Y (TTM)9.22%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%4.24%
EPS Next Y-2.34%
EPS Next 2Y-0.8%
EPS Next 3Y1.99%
EPS Next 5Y1.94%
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%2.87%
Revenue Next Year-4.32%
Revenue Next 2Y-2.38%
Revenue Next 3Y-0.89%
Revenue Next 5Y-0.29%
EBIT growth 1Y24.37%
EBIT growth 3Y-8.8%
EBIT growth 5Y-18.9%
EBIT Next Year14.01%
EBIT Next 3Y5.48%
EBIT Next 5Y5.69%
FCF growth 1Y103.57%
FCF growth 3Y-9.06%
FCF growth 5Y-17.06%
OCF growth 1Y85.85%
OCF growth 3Y-7.56%
OCF growth 5Y-16.49%